Cytek Biosciences Reports Third Quarter 2021 Financial Results
November 08, 2021 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the third quarter ended September 30,...
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
November 03, 2021 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has acquired the cell analysis business...
Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
October 26, 2021 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter...
Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
October 07, 2021 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- The field of medical research has a new tool to develop vaccines, personal immunotherapies, and cures for cancer and other infectious diseases using...
Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
September 02, 2021 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley...
Cytek Biosciences Reports Second Quarter 2021 Financial Results
September 02, 2021 16:03 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30,...
Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 02, 2021 16:01 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that the...
Cytek Biosciences Announces Closing of Its Initial Public Offering
July 27, 2021 18:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the closing of...
Cytek Biosciences Announces Pricing of Its Initial Public Offering
July 22, 2021 22:43 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of...
New Plate Loader from Cytek® Biosciences Delivers Expanded Capabilities for High-Parameter, High-Throughput Single Cell Analysis
June 22, 2021 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc., a leading cell analysis solutions company, today introduced a new plate loader – the Automated Sample Loader (ASL)....